Jim Gollan has over 25 years experience operating at Board level in financial services both as executive and non executive director. Currently, Jim is a non executive Director and Chair of Audit Committee of Citibank Europe and Non Executive Director and Chair of Audit Committee for Euronext NV and he is the Chair of the Board for Euronext London. Previously, his roles included Chair of the Board Bank of America Merrill Lynch International Ltd.
Jonathan Kropman is a Partner at lawyers,Trowers and Hamlins LLP, where he leads the international private client group; previously he held the same role as a Partner at Berwin Leighton Paisner LLP. Jonathan’s legal practice includes advising on governance, holding structures, investment and shareholders’ agreements for the wealth management industry and the firm’s private client base. He is also a Trustee of Weizmann Institute Foundation, a registered charity.
Jerry Storrs is a Chartered Accountant and Corporate Treasurer and currently works as an independent advisor and board director. In a wide-ranging career, most recently specialising in corporate debt restructuring and the sale of "non-core" assets, he has negotiated numerous high profile and high value transactions. During a secondment to the Civil Service he advised ministers on corporate finance transactions and policy. Earlier in his career he held senior roles in banking as a divisional COO / CFO.
Aoife Regan has over 15 years' experience of working in one of the largest fundraising charities in the world – Cancer Research UK. She is currently Head of Experimental Cancer Medicine there and her previous roles include Head of Research Evaluation and Senior Strategy Manager. She has a PhD in Developmental Neuroscience.
Doug Turnbull is a Professor of Neurology at Newcastle University, an Honorary Consultant Neurologist at Newcastle upon Tyne Hospitals and the Director of the Wellcome Trust Centre for the Institute of Neuroscience at Newcastle University. His areas of expertise are mitochondrial disease and neurology. He is a Fellow of the Royal Society.
John Pickard is Professor Emeritus of Neurosurgery in the Department of Clinical Neurosciences at the University of Cambridge and Honorary Director of the National Institute for Health Research's Healthcare Technology Cooperative (HTC) for brain injury. His research focuses on advancing the care of patients with acute brain injury, hydrocephalus and prolonged disorders of consciousness through functional brain imaging, studies of pathophysiology and new treatments.
Professor Joanna Wardlaw, CBE, MD, FRSE, FMedSci, is Professor of Applied Neuroimaging at the University of Edinburgh, Foundation Chair in the UK Dementia Research Institute, and Consultant Neuroradiologist for NHS Lothian. Her work focuses on understanding the brain and its blood supply, and on treatments to improve blood flow to the brain, including thrombolytic drugs that are now in routine use to treat stroke, and more recently on treatments for small vessel disease and dementia.
Paul Wright is currently a non-executive director of fibodo and of qodeo, both early stage tech-enabled businesses. His executive career included 40 years as a Finance Director/CFO in various financial services businesses, including Towry, Man Investments, Coutts and Standard Chartered, as well as experience in venture capital and private equity.